Skip to main content
Clinical Trials/NCT00900913
NCT00900913
Completed
Phase 4

Effect of Systemic Ropivacaine on Hyperalgesia, Flare Reaction and Peripheral

University of Zurich1 site in 1 country34 target enrollmentJanuary 2010

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Healthy Volunteers
Sponsor
University of Zurich
Enrollment
34
Locations
1
Primary Endpoint
Aera of flare reaction (cm2), area of primary and secondary hyperalgesia (cm2)
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this study is to compare the effect of intravenous ropivacaine and lidocaine on the receptive field of primary sensory afferents and their influence on the vascular bed.

*Trial with medicinal product

Registry
clinicaltrials.gov
Start Date
January 2010
End Date
July 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Aera of flare reaction (cm2), area of primary and secondary hyperalgesia (cm2)

Time Frame: 1 year

Study Sites (1)

Loading locations...

Similar Trials